Ondansetron Tablet, Orally Disintegrating
Product Images NDC 85534-0025

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 85534-0025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hawaii Repack, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4 (Label 4mg)

Packaging labels for Ondansetron ODT, USP 4 mg orally disintegrating tablets distributed by Hawaii Repack, Inc., showing three different quantities: 10, 20, and 30 tablets. Each label includes the product name, strength, NDC codes, distributor address, description of the tablet appearance, and regulatory statements regarding prescription status and storage instructions.*

FDA Label Image

8 (Label 8mg)

Packaging labels for Ondansetron ODT 8 mg orally disintegrating tablets from Hawaii Repack, Inc. Each label shows quantity options of 10, 20, and 30 tablets. Labels include NDC numbers, distributor information (Aurobindo Pharma USA, Inc.), storage instructions, and legal cautions about prescription use and child safety.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical structure diagram of ondansetron, showing its molecular arrangement with distinct ring systems and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.